Reports for APOTEX INC
Formerly known as AA PHARMA INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
26 (7%)
Discontinued:
343 (93%)
Reversed:
0 (0%)
369
145 (4%)
73 (30%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-METHOTREXATE | 2.5MG | TABLET | Actual shortage | 2025-05-01 | 2025-05-01 | 256312 |
| APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2023-11-06 | 2023-12-01 | 209351 |
| APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2024-04-12 | 2024-05-10 | 224980 |
| APO-METHYLPHENIDATE | 20MG | TABLET | Resolved | 2021-04-05 | 2021-05-17 | 136799 |
| APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2019-01-09 | 2019-02-08 | 71673 |
| APO-METHYLPHENIDATE | 20MG | TABLET | Resolved | 2018-07-04 | 2018-10-11 | 54288 |
| APO-METHYLPHENIDATE | 20MG | TABLET | Resolved | 2019-05-29 | 2019-07-12 | 85156 |
| APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2022-05-20 | 2022-06-22 | 161029 |
| APO-METHYLPHENIDATE | 20MG | TABLET | Resolved | 2017-11-22 | 2018-01-25 | 30084 |
| APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2023-09-07 | 2023-10-20 | 203812 |
| APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2022-03-18 | 2022-04-18 | 156993 |
| APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2019-03-20 | 2019-07-06 | 79048 |
| APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2018-03-05 | 2018-04-20 | 41858 |
| APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2021-10-22 | 2021-12-09 | 147818 |
| APO-METHYLPHENIDATE | 5MG | TABLET | Resolved | 2018-01-18 | 2018-03-13 | 36446 |
| APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2024-04-26 | 2024-05-10 | 226327 |
| APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2023-03-23 | 2023-04-27 | 187724 |
| APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2024-06-20 | 2024-07-19 | 231036 |
| APO-METHYLPHENIDATE | 5MG | TABLET | Resolved | 2024-03-08 | 2024-05-10 | 221723 |
| APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2018-05-15 | 2018-09-12 | 49496 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-FENTANYL MATRIX | 25MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60489 |
| APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
| APO-FENTANYL MATRIX | 75MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60497 |
| APO-FENTANYL MATRIX | 100MCG | PATCH | Discontinued | 2018-02-23 | 2018-12-28 | 40741 |
| APO-FLUNISOLIDE NASAL SPRAY | 0.25MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40965 |
| APO-FLUVOXAMINE TABLETS | 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4713 |
| APO-FLUVOXAMINE TABLETS | 50MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4716 |
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2018-02-26 | 2018-02-26 | 40997 |
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2019-01-02 | 2019-01-02 | 70815 |
| APO-GEMFIBROZIL | 600MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4927 |
| APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 | ||
| APO-GEMFIBROZIL CAP 300MG USP | 300MG | CAPSULE | Discontinued | 2017-03-31 | 2018-12-07 | 4920 |
| APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94452 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94446 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94449 | ||
| APO-HALOPERIDOL TAB 2MG | 2MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1084 |
| APO-HALOPERIDOL TAB 5MG | 5MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1087 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |